Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

Stefan H Faderl, Deborah A Thomas, Susan O'Brien, Guillermo Garcia-Manero, Hagop M. Kantarjian, Francis J. Giles, Charles A Koller, Alessandra Ferrajoli, Srdan Verstovsek, Barbara Pro, Michael Andreeff, Miloslav Beran, Jorge E Cortes, William Wierda, Ngoc Tran, Michael J. Keating